Table 1.
SIENNA™ COVID-19 Antigen Rapid Test Cassettea |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N gene Ct by rRT-PCR (median; range) | N | TP (n) | FN (n) | Sensitivityb(% [95% CI])g | Specificityb(% [95% CI]) | Agreementc | Concordanced | Youden’s J indexe | PPVf(% [95% CI]) | NPVf(% [95% CI]) | ||
N gene Cth of positive samples by reference rRT-PCRi | ≤20 | 19 (9-20) | 25 | 25 | 0 | 100.0 [99.9–100.0] | 100.0 [99.9–100.0] | 100.0 | 1.0 | 1.0 | 100.0 [99.9–100.0] | 100.0 [99.9–100.0] |
21–33 | 25 (21–33) | 52 | 49 | 3 | 94.2 [87.9–100.0] | 100.0 [99.9–100.0] | 97.0 | 0.94 | 0.94 | 100.0 [99.9–100.0] | 98.9 [96.1–100.0] | |
>33 | 35 (34–37) | 23 | 16 | 7 | 69.6 [50.7–88.0] | 100.0 [99.9–100.0] | 90.4 | 0.76 | 0.70 | 92.1 [86.0 –95.7] | 94.4 [88.5–100.0] | |
All Ct values | 24 (9–37) | 100 | 90 | 10 | 90.0 [84.1–95.9] | 100.0 [99.9–100.0] | 93.3 | 0.86 | 0.90 | 100.0 [99.9–100.0] | 98.1 [94.6–100.0] |
Ct: cycle threshold; FN: false negative; FP: false positive; NPV: negative predictive value; PPV: positive predictive value; rRT-PCR: real-time reverse transcription-polymerase chain reaction; TP: true positive; TN: true negative.
Nasopharyngeal samples were collected with a flocked swab, then discarded in 1 ml of physiological saline, and further stored frozen at −80 °C before reuse;
All 50 swab samples negative by reference rRT-PCR were found negative by the test SIENNA™ COVID-19 Antigen Rapid Test Cassette (Nasopharyngeal Swab); the values of TN and FN were 50 and 0, respectively;
Agreement = TP + TN/TP + FP + TN + FN, expressed in percentage;
The Cohen’s k coefficient calculation was used to estimate the concordance (Cohen, 1960) and interpreted according the Landis and Koch scale (Landlis and Koch, 1977), as follows: <0 as indicating no agreement, 0–0.20 as slight, 0.21–0.40 as fair, 0.41–0.60 as moderate, 0.61–0.80 as substantial, and 0.81–1 as almost perfect concordance;
The accuracy of the test SIENNA™ COVID-19 Antigen Rapid Test Cassette (Nasopharyngeal Swab) to correctly diagnose SARS-CoV-2 infection was estimated by Youden’s J index (J = sensitivity + specificity − 1) (Youden, 1950);
PPV and NPV were calculated according to the Bayes’s formulae, by taking into account the official reported prevalence of SARS-CoV-2-RNA positivity in COVID-19-suspected patients in Paris’s area, France, of 16.2% on 17th November 2020 [Santé publique France, 2020; https://www.santepubliquefrance.fr/];
95% confidence intervals in brackets were calculated by using the Wilson score bounds;
The Ct values of N gene detection by the reference Seegene rRT-PCR were used to classify nasopharyngeal samples according to their level of SARS-CoV-2 RNA excretion; Ct of 20 and 33 were taken as thresholds of very high and high SARS-CoV-2 RNA excretion, respectively, as previously stated (Centers for Disease Control and Prevention, 2020b; Jefferson et al., 2020; Société Française de Microbiologie, 2020; Yu et al., 2020);
The CE IVD-marked Allplex™ 2019-nCoV Assay (Seegene, Séoul, Korée) constituted the reference multiplex rRT-PCR for SARS-CoV-2 RNA detection. This assay detects three target genes of SARS-CoV-2 (E, RdRP and N genes) (Farfour et al., 2020).